MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mpg.0000000000002522

Медицинская библиотека · Journal of pediatric gastroenterology and nutrition · 2020

Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children.

Deneau Mark R, Valentino Pamela L, Mack Cara, Alqoaer Khaled, Amin Mansi, Amir Achiya Z, Aumar Madeleine, Auth Marcus, Broderick Annemarie, DiGuglielmo Matthew, Draijer Laura G, El-Matary Wael, Ferrari Federica, Furuya Katryn N, Gottrand Frederic, Gupta Nitika, Homan Matjaz, Jensen M K, Kamath Binita M, Kim Kyung Mo, Kolho Kaija-Leena, Koot Bart, Iorio Raffaele, Martinez Mercedes, Miloh Tamir, Mohan Parvathi, Palle Sirish, Papadopoulou Alexandra, Ricciuto Amanda, Saubermann Lawrence, Sathya Pushpa, Shteyer Eyal, Smolka Vratislav, Tanaka Atsushi, Varier Raghu, Venkat Veena, Vitola Bernadette, Woynarowski Marek, Guthery Stephen

Оценочное исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Natural history models for primary sclerosing cholangitis (PSC) are derived from adult patient data, but have never been validated in children. It is unclear how accurate such models are for children with PSC.

METHODS

We utilized the pediatric PSC consortium database to assess the Revised Mayo Clinic, Amsterdam-Oxford, and Boberg models. We calculated the risk stratum and predicted survival for each patient within each model using patient data at PSC diagnosis, and compared it with observed survival. We evaluated model fit using the c-statistic.

RESULTS

Model fit was good at 1 year (c-statistics 0.93, 0.87, 0.82) and fair at 10 years (0.78, 0.75, 0.69) in the Mayo, Boberg, and Amsterdam-Oxford models, respectively. The Mayo model correctly classified most children as low risk, whereas the Amsterdam-Oxford model incorrectly classified most as high risk. All of the models underestimated survival of patients classified as high risk. Albumin, bilirubin, AST, and platelets were most associated with outcomes. Autoimmune hepatitis was more prevalent in higher risk groups, and over-weighting of AST in these patients accounted for the observed versus predicted survival discrepancy.

CONCLUSIONS

All 3 models offered good short-term discrimination of outcomes but only fair long-term discrimination. None of the models account for the high prevalence of features of autoimmune hepatitis overlap in children and the associated elevated aminotransferases. A pediatric-specific model is needed. AST, bilirubin, albumin, and platelets will be important predictors, but must be weighted to account for the unique features of PSC in children.

Для цитирования: Deneau Mark R, Valentino Pamela L, Mack Cara, Alqoaer Khaled, Amin Mansi, Amir Achiya Z, Aumar Madeleine, Auth Marcus, Broderick Annemarie, DiGuglielmo Matthew, Draijer Laura G, El-Matary Wael, Ferrari Federica, Furuya Katryn N, Gottrand Frederic, Gupta Nitika, Homan Matjaz, Jensen M K, Kamath Binita M, Kim Kyung Mo, Kolho Kaija-Leena, Koot Bart, Iorio Raffaele, Martinez Mercedes, Miloh Tamir, Mohan Parvathi, Palle Sirish, Papadopoulou Alexandra, Ricciuto Amanda, Saubermann Lawrence, Sathya Pushpa, Shteyer Eyal, Smolka Vratislav, Tanaka Atsushi, Varier Raghu, Venkat Veena, Vitola Bernadette, Woynarowski Marek, Guthery Stephen. Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children.. Journal of pediatric gastroenterology and nutrition. 2020. DOI: 10.1097/mpg.0000000000002522.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.